Table-I.
Corneal neovascular invasion area among the two groups
| Week 4 | Week 8 | Week 12 | Week 24 | |
|---|---|---|---|---|
| Group A (Bevacizumab ) | 12.5 | 9.7 | 10.5 | 9.3 |
| Group B (Control) | 14.2 | 18.3 | 19.8 | 26.7 |
P =0.03
Corneal neovascular invasion area among the two groups
| Week 4 | Week 8 | Week 12 | Week 24 | |
|---|---|---|---|---|
| Group A (Bevacizumab ) | 12.5 | 9.7 | 10.5 | 9.3 |
| Group B (Control) | 14.2 | 18.3 | 19.8 | 26.7 |
P =0.03